Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
The Gabelli Healthcare & Wellness Trust | GRX | 15. nov 2024 | 10.10 | -2.04 |
The Gdl Fund | GDL | 15. nov 2024 | 8.08 | -0.62 |
The Glimpse Group | VRAR | 15. nov 2024 | 0.58 | -17.04 |
The Hackett Group | HCKT | 15. nov 2024 | 30.32 | -1.59 |
The Hain Celestial Group | HAIN | 15. nov 2024 | 7.24 | +5.54 |
The Hershey | HSY | 15. nov 2024 | 170.92 | -4.48 |
The Herzfeld Caribbean Basin Fund | CUBA | 15. nov 2024 | 2.48 | -1.59 |
The Honest Company | HNST | 15. nov 2024 | 6.91 | +6.31 |
The Intergroup | INTG | 15. nov 2024 | 14.34 | 0.00 |
The J.M Smucker Company | SJM | 15. nov 2024 | 106.92 | -3.46 |
The Joint | JYNT | 15. nov 2024 | 11.06 | -1.43 |
The Marygold Companies | MGLD | 15. nov 2024 | 1.28 | -4.48 |
The ODP | ODP | 15. nov 2024 | 25.18 | -0.75 |
The OLB Group | OLB | 15. nov 2024 | 1.89 | +2.16 |
The Oncology Institute | TOI | 15. nov 2024 | 0.18 | -23.47 |
The ONE Group Hospitality | STKS | 15. nov 2024 | 3.02 | +1.34 |
The Pennant Group | PNTG | 15. nov 2024 | 31.43 | -1.47 |
The Real Brokerage | REAX | 15. nov 2024 | 4.95 | -4.26 |
The Real Estate Select Sector SPDR Fund | XLRE | 15. nov 2024 | 42.98 | +0.12 |
The RealReal | REAL | 15. nov 2024 | 3.99 | 0.00 |
The RMR Group A | RMR | 15. nov 2024 | 22.19 | -1.47 |
The Shyft Group | SHYF | 15. nov 2024 | 13.92 | -1.49 |
The Trade Desk A | TTD | 15. nov 2024 | 118.15 | -6.14 |
The9 ADR | NCTY | 15. nov 2024 | 11.14 | -1.42 |
TherapeuticsMD | TXMD | 15. nov 2024 | 1.40 | -4.11 |
Theratechnologies | THTX | 15. nov 2024 | 1.18 | -2.48 |
Theravance Biopharma | TBPH | 15. nov 2024 | 9.52 | -0.52 |
Theriva Biologics | TOVX | 15. nov 2024 | 1.36 | +0.74 |
Thermo Fisher Scientific | TMO | 15. nov 2024 | 513.08 | -3.74 |
Thermon Group | THR | 15. nov 2024 | 29.71 | +0.34 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.